Eurofins Scientific (0MV5) Share Forecast & Price Target

Compare

5 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0MV5 Analyst Ratings

Moderate Buy

1 Buy

0 Hold

0 Sell

Based on 1 analysts giving stock ratings to

Eurofins

Scientific

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0MV5 Stock 12 Month Forecast

Average Price Target

€72.00

▲(25.09% Upside)

Based on 1 Wall Street analysts offering 12 month price targets for Eurofins Scientific in the last 3 months. The average price target is €72.00 with a high forecast of €72.00 and a low forecast of €72.00. The average price target represents a 25.09% change from the last price of €57.56.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"44":"€44","73":"€73","51.25":"€51.3","58.5":"€58.5","65.75":"€65.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":72,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€72.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€72.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€72.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[44,51.25,58.5,65.75,73],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"Jun<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.89,63.59076923076923,64.29153846153847,64.99230769230769,65.69307692307693,66.39384615384616,67.09461538461538,67.79538461538462,68.49615384615385,69.19692307692307,69.89769230769231,70.59846153846154,71.29923076923077,{"y":72,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.89,63.59076923076923,64.29153846153847,64.99230769230769,65.69307692307693,66.39384615384616,67.09461538461538,67.79538461538462,68.49615384615385,69.19692307692307,69.89769230769231,70.59846153846154,71.29923076923077,{"y":72,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,62.89,63.59076923076923,64.29153846153847,64.99230769230769,65.69307692307693,66.39384615384616,67.09461538461538,67.79538461538462,68.49615384615385,69.19692307692307,69.89769230769231,70.59846153846154,71.29923076923077,{"y":72,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":45.78,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.78,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.45,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.21,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.39,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.64,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.46,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.78,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.34,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.66,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.89,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€72.00

Average Price Target€72.00

Lowest Price Target€72.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Francois Digard

Kepler Capital

€68→€72

Buy

25.09%

Upside

Reiterated

10/30/25

Remi Grenu

Morgan Stanley

€59→€61

Hold

5.98%

Upside

Reiterated

09/10/25

Eurofins Scientific (0MV5) Receives a Hold from Morgan Stanley

Carl Raynsford

Berenberg Bank

€62

Hold

7.71%

Upside

Reiterated

07/28/25

Eurofins Scientific (0MV5) Gets a Hold from Berenberg Bank

James Rose

Barclays

€50→€54

Hold

-6.18%

Downside

Reiterated

07/16/25

Barclays Remains a Hold on Eurofins Scientific (0MV5)

Shubhangi Gupta

HSBC

€70→€48

Hold

-16.61%

Downside

Downgraded

04/25/25

HSBC Downgrades Eurofins Scientific SE (ERF:FP) (ERFSF) to HoldHSBC analyst Shubhangi Gupta downgraded Eurofins Scientific SE (ERF:FP) (OTC: ERFSF) from Buy to Hold with a price target of EUR48.00 (from EUR70.00).

Arthur Truslove

Citi

€53→€55.6

Hold

-3.41%

Downside

Reiterated

04/24/25

Eurofins Scientific SE (ERF:FP) (ERFSF) PT Raised to EUR55.60 at CitiCiti analyst Arthur Truslove raised the price target on Eurofins Scientific SE (ERF:FP) (OTC: ERFSF) to EUR55.60 (from EUR53.00) while maintaining a Neutral rating.

Allen Wells

Jefferies

€42→€43

Sell

-25.30%

Downside

Reiterated

03/31/25

Eurofins Scientific SE (ERF:FP) (ERFSF) PT Raised to EUR43 at JefferiesJefferies analyst Allen Wells raised the price target on Eurofins Scientific SE (ERF:FP) (OTC: ERFSF) to EUR43.00 (from EUR42.00) while maintaining a Underperform rating.

Dominic Edridge

Deutsche Bank

€50→€53

Hold

-7.92%

Downside

Reiterated

02/13/25

Eurofins Scientific SE (ERF:FP) (ERFSF) PT Raised to EUR53 at Deutsche BankDeutsche Bank analyst Dominic Edridge raised the price target on Eurofins Scientific SE (ERF:FP) (OTC: ERFSF) to EUR53.00 (from EUR50.00) while maintaining a Hold rating.

Suhasini Varanasi

Goldman Sachs

€89→€90

Buy

56.36%

Upside

Reiterated

12/19/24

Eurofins Scientific SE (ERF:FP) (ERFSF) PT Raised to EUR90 at Goldman SachsGoldman Sachs analyst Suhasini Varanasi raised the price target on Eurofins Scientific SE (ERF:FP) (OTC: ERFSF) to EUR90.00 (from EUR89.00) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Francois Digard

Kepler Capital

€68→€72

Buy

25.09%

Upside

Reiterated

10/30/25

Remi Grenu

Morgan Stanley

€59→€61

Hold

5.98%

Upside

Reiterated

09/10/25

Eurofins Scientific (0MV5) Receives a Hold from Morgan Stanley

Carl Raynsford

Berenberg Bank

€62

Hold

7.71%

Upside

Reiterated

07/28/25

Eurofins Scientific (0MV5) Gets a Hold from Berenberg Bank

James Rose

Barclays

€50→€54

Hold

-6.18%

Downside

Reiterated

07/16/25

Barclays Remains a Hold on Eurofins Scientific (0MV5)

Shubhangi Gupta

HSBC

€70→€48

Hold

-16.61%

Downside

Downgraded

04/25/25

Arthur Truslove

Citi

€53→€55.6

Hold

-3.41%

Downside

Reiterated

04/24/25

Allen Wells

Jefferies

€42→€43

Sell

-25.30%

Downside

Reiterated

03/31/25

Dominic Edridge

Deutsche Bank

€50→€53

Hold

-7.92%

Downside

Reiterated

02/13/25

Suhasini Varanasi

Goldman Sachs

€89→€90

Buy

56.36%

Upside

Reiterated

12/19/24

Stocks with the Highest Top Analyst Consensus in the Services Sector

xxx

Find stocks in the Services sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Eurofins Scientific

1 Month

xxx

Success Rate

4/9 ratings generated profit

Average Return

+0.16%

reiterated a xxx

rating 12 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of +0.16% per trade.

3 Months

xxx

Success Rate

6/9 ratings generated profit

Average Return

+8.27%

reiterated a xxx

rating 12 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +8.27% per trade.

1 Year

Suhasini VaranasiGoldman Sachs

Success Rate

5/9 ratings generated profit

Average Return

+13.79%

reiterated a buy rating 12 months ago

Copying Suhasini Varanasi's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +13.79% per trade.

2 Years

xxx

Success Rate

6/9 ratings generated profit

Average Return

+14.50%

reiterated a xxx

rating 12 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +14.50% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0MV5 Analyst Recommendation Trends

Rating

Apr 25

Jun 25

Jul 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0MV5 has received 3 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. 0MV5 average Analyst price target in the past 3 months is 72.00.

Each month's total comprises the sum of three months' worth of ratings.

0MV5 Financial Forecast

0MV5 Earnings Forecast

Next quarter’s earnings estimate for 0MV5 is €1.27 with a range of €1.27 to €1.27. The previous quarter’s EPS was €1.64. 0MV5 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.89% of the time in the same period. In the last calendar year 0MV5 has Performed in-line its overall industry.

0MV5 Sales Forecast

Next quarter’s sales forecast for 0MV5 is €3.71B with a range of €3.71B to €3.71B. The previous quarter’s sales results were €3.61B. 0MV5 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 85.94% of the time in the same period. In the last calendar year 0MV5 has Performed in-line its overall industry.

0MV5 Stock Forecast FAQ

What is GB:0MV5’s average 12-month price target, according to analysts?

Based on analyst ratings, Eurofins Scientific’s 12-month average price target is 72.00.

What is GB:0MV5’s upside potential, based on the analysts’ average price target?

Eurofins Scientific has 25.09% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Eurofins Scientific a Buy, Sell or Hold?

Eurofins Scientific has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.

What is Eurofins Scientific’s share price target?

The average share price target for Eurofins Scientific is 72.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €72.00 ,and the lowest forecast is €72.00. The average share price target represents 25.09% Increase from the current price of €57.56.

What do analysts say about Eurofins Scientific?

Eurofins Scientific’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Eurofins Scientific?

To buy shares of GB:0MV5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Eurofins Scientific (0MV5) Share Forecast & Price Target

0MV5 Analyst Ratings

0MV5 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Eurofins Scientific

0MV5 Analyst Recommendation Trends

0MV5 Financial Forecast

0MV5 Earnings Forecast

0MV5 Sales Forecast

0MV5 Stock Forecast FAQ

Detailed List of Analyst Forecasts